News | March 12, 2024
AstraZeneca Pharma India, Mankind Pharma ink pact to distribute asthma medicine
India is contributing 13% to the global asthma burden and a disproportionate 43% of the global asthma deaths.
India is contributing 13% to the global asthma burden and a disproportionate 43% of the global asthma deaths.
CRESEMBA receives seven years and six months of US market exclusivity for these pediatric indications
The Cabinet has approved budgetary support of Rs. 2207.50 crore in the 15th Finance Commission Cycle to run CAPFIMS as a campus of AIIMS, New Delhi.
Zydus Lifesciences receives EIR report from USFDA for API Ahmedabad facility
The institution will be spread over an area of more than 8 acres
Women emerge as the cornerstone of this monumental undertaking
These approvals mark significant progress for Venus Remedies in expanding its market presence
The plan is to set up an ultramodern Solvent Recovery Plant for third party purposes
The investment will catalyse various components of the IndiaAI Mission
Earlier, he worked with Cadila Pharmaceuticals Limited, Cipla, Alkem Laboratories, and Wockhardt, and started his career with Novartis
Subscribe To Our Newsletter & Stay Updated
